Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback